Villejuif
France
University of Paris-Saclay - Department of Hematology
T-cell engager, infections, haematological malignancy, solid tumour
Convalescent plasma, COVID-19, Hematological malignancies, Anti-CD20, B-cell deficiency
G-CODE, geriatric assessment, phase 1 clinical trials, older adults, feasibility, Toxicity